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Background: Obesity is a pressing public health concern, which frequently presents in primary care. With the
explosive obesity epidemic, there is an urgent need to maximize effective management in primary care. The 5As of
Obesity Management™ (5As) are a collection of knowledge tools developed by the Canadian Obesity Network. Low
rates of obesity management visits in primary care suggest provider behaviour may be an important variable. The
goal of the present study is to increase frequency and quality of obesity management in primary care using the
5As Team (5AsT) intervention to change provider behaviour.
Methods/design: The 5AsT trial is a theoretically informed, pragmatic randomized controlled trial with mixed
methods evaluation. Clinic-based multidisciplinary teams (RN/NP, mental health, dietitians) will be randomized to
control or the 5AsT intervention group, to participate in biweekly learning collaborative sessions supported by
internal and external practice facilitation. The learning collaborative content addresses provider-identified barriers to
effective obesity management in primary care. Evidence-based shared decision making tools will be co-developed
and iteratively tested by practitioners. Evaluation will be informed by the RE-AIM framework. The primary outcome
measure, to which participants are blinded, is number of weight management visits/full-time equivalent (FTE) position.
Patient-level outcomes will also be assessed, through a longitudinal cohort study of patients from randomized
practices. Patient outcomes include clinical (e.g., body mass index [BMI], blood pressure), health-related quality of life
(SF-12, EQ5D), and satisfaction with care. Qualitative data collected from providers and patients will be evaluated using
thematic analysis to understand the context, implementation and effectiveness of the 5AsT program.
Discussion: The 5AsT trial will provide a wide range of insights into current practices, knowledge gaps and barriers
that limit obesity management in primary practice. The use of existing resources, collaborative design, practice
facilitation, and integrated feedback loops cultivate an applicable, adaptable and sustainable approach to increasing
the quantity and quality of weight management visits in primary care.
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Obesity is a common problem in primary care [1,2]. There
are substantial direct and indirect costs to the healthcare
system; conservative estimate of costs attributable to obes-
ity in Alberta in 2005 totaled $1.27 billion [3]. Studies sug-
gest that a primary care-based obesity treatment model
could be cost-effective over the long term [2] and that
treating obesity can reduce the incidence of a variety of
chronic diseases [4-7]. However, obesity is ‘not effectively
managed within our current primary health system’ [4-6].
To address this problem, a tool for obesity counseling and
management in primary care settings, known as the 5As
of Obesity Management™ has been developed [7]. This
tool incorporates the conceptual structure of the Best
Practices in Weight Management document, the Canadian
Obesity Clinical Practice Guidelines [8], and the 5As
methodological framework (Ask, Assess, Advise, Agree,
Assist) [9]. Preliminary evidence shows that use of the 5As
of Obesity Management can increase provider-client inter-
actions in weight management [10]. However, the 5As
have not been evaluated in a system-wide implementation
study.
The Primary Care Network (PCN) model in Alberta
has a 10-year history of embedding multidisciplinary
teams in pre-existing family physician clinics. Chronic
disease nurses and nurse practitioners working in this
multi-disciplinary setting (with family physicians, mental
health workers and dieticians) present a good model to
target and assess improvement in obesity management.
The goal of this project is to implement and evaluate
the 5AsT team intervention aimed at changing provider
behaviour with regard to obesity management. This inter-
vention, informed by the theoretical domains framework
for behaviour change and the conceptual framework of
complex innovation implementation, is co-developed with
end-users, emphasizing bidirectional knowledge transfer
among multidisciplinary team members to develop a prag-




The 5AsT trial is a theoretically informed, pragmatic ran-
domized controlled trial with convergent mixed methods
evaluation of an intervention on primary care providers to
improve obesity management. Clinic-based multidisciplin-
ary teams (RN/NP, mental health, dieticians) will be ran-
domized to control or the 5AsT intervention group. The
intervention providers will participate in biweekly learning
collaborative sessions supported by internal and external
practice facilitation. These learning collaboratives will ex-
plore provider-identified barriers to effective weight man-
agement in primary care. Evidence-based shared decision
making tools will be co-developed and iteratively tested bypractitioners. The primary outcome measure is the num-
ber of weight management visits per full-time equivalent
(FTE) RN/NP position. This measure is longstanding, rou-
tine administrative data in the PCN. Participants are un-
aware of the primary outcome measure, and the research
team is blinded to the result during the study period.
Patient-level outcomes will be assessed, through a longitu-
dinal cohort study of patients from randomized practices.
Qualitative data will be collected from providers and pa-
tients, and evaluated using thematic analysis to under-
stand the context, implementation and the effectiveness of
the 5AsT intervention. Patient-level outcomes including
clinical, health-related quality of life, and satisfaction with
care will also be assessed.
Figure 1 provides an overview of the 5AsT trial, which
consists of both a provider-level intervention study and
a patient-level impact assessment. The 5AsT provider-
level study is divided into three phases. Phase 1 is the
‘Intervention Phase,’ which consists of a kick-off session
followed by bi-weekly two-hour learning collaborative
sessions over six months. Phase 2 is the ‘Passive Phase,’ a
six-month period where we provide no direct support to
the 5As Teams but continue to collect data to determine
if behavior change has been internalized. Phase 3 is the
‘sustainability phase,’ where the primary outcome measure
continues to be collected over 12 months to determine if
change can be sustained over time. The patient-level study
will assess how patients coming from 5AsT intervention
practices engage in weight management efforts over time
compared to patients from control practices.
Guiding theoretical frameworks
Conceptual framework of complex innovation
implementation
Complex innovations such as behavioral change interven-
tions in primary care can be conceived using this validated
framework [11]. Our alignment with this framework re-
duces the chance that context change will negatively affect
implementation or completion of the project. This frame-
work informed the decision to have a clinical champion
act as an internal practice facilitator from within the pri-
mary care network.
Theoretical domains framework for behaviour change
The Theoretical Domains Framework is a validated, com-
prehensive overview of the core domains important to
consider in behavioural change interventions in healthcare
improvement [4]. This Framework informs our interven-
tion on the practitioners to expand from knowledge alone,
towards engaging in all components critical for their
behaviour change. The 5AsT intervention leverages the
clinical champion role for coaching and, the practice fa-
cilitation role to aid in logistical support, and the learning
collaborative model to increase role identification, goal
Figure 1 5AsT study overview. The upper portion pertains to the provider-level study and shows intervention and evaluation timeline. The
lower portion pertains to the parallel patient-level study.
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We also used this framework to determine the target
patient population. The patient study focuses on patients
who have committed to action prior to recruitment (‘acti-
vated patients’), assessing their ability to initiate and sus-
tain weight management efforts.
Guiding evaluation framework: RE-AIM
Our overall evaluation summarized in Table 1, is guided
by the RE-AIM framework: Reach into the target popu-
lation; Effectiveness of the intervention; Adoption by tar-
get settings; Implementation including consistency and
cost of delivery; and Maintenance of intervention effects
over time (sustainability) [5,6,12,13].
Setting/population
The 5AsT intervention was designed with our partner
primary care network (PCN), which consists of 59 de-
dicated multidisciplinary healthcare providers (nurses,
nurse practitioners, mental health workers, dieticians,
exercise physiologists, respiratory therapists) embedded
in 46 family practices with over 160 family physiciansserving 192 655 Albertans. The PCN has been in a
period of rapid growth.
At the practice level, the RN/NPs in the PCN are re-
sponsible for significant chronic disease management,
including diabetes and weight management, as well as
prenatal care.
To be eligible to be randomized to the intervention,
PCN-affiliated family practice clinics must have joined
the PCN by April 2013, and must have a multidiscipli-
nary team including a nurse/nurse practitioner, mental
health worker and a dietician affiliated with the clinic,
resulting in 24 eligible clinic teams. The intervention
unit is the PCN multidisciplinary team affiliated with the
clinic, referred to as the ‘5AsT team.’
Patients are eligible to be recruited to the longitudinal
cohort study if they declare activation for behaviour
change through their enrolment and participation in one
of the PCN programs for health (e.g., weight manage-
ment groups, activity groups, mental health groups).
These are run independently from the clinic-based
5AsT team. Patients are eligible regardless of what clinic
they attend for their regular care.
Table 1 RE-AIM framework as a guide for project evaluation
Domain Description Measure for patients Measure for providers
Reach Degree to which target population is reached • number recruited • Control/intervention groups
• percent attrition • Intervention attendance
• patient characteristics • Provider-chosen topics (subject appropriateness)
Effectiveness Impact on study outcome • SF 12 • Quantitative primary
• BMI outcome measure
• 5AsT vs. non 5AsT patients • Self-reported efficacy
Adaptation Organizational uptake Not applicable • Sustainability phase
• Repeat provider interviews




Maintenance Can program outcomes be sustained over time? • Longitudinal data collection • Longitudinal data collection
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The 5AsT intervention builds upon the knowledge pro-
duct of the 5As of Obesity Management™ and extends it
to a pragmatic, practice-based intervention for provider
behaviour change. The 5AsT intervention will occur in
biweekly learning collaborative sessions for six months.
The content of the 5AsT learning collaborative sessions
will be determined with the practitioners randomized to
the intervention. The 5As teams will be supported by a
5As Champion, a recognized clinical leader in weight
management from the PCN. This individual is identified
and remunerated through the PCN and functions as an
internal practice facilitator for the project. In addition to
assisting the research team with coordinating their
actions with the clinical operations of the PCN, the
Clinical Champion serves as a coach and mentor to the
5AsT team members, and as a facilitator for the learning
collaborative. Additional support to the 5AsT teams is
provided by two external practice facilitators who iden-
tify resources, design prototype tools, collect feedback
and coordinate with content experts, physicians, and
graphic designers to refine the 5AsT tools.
Providers randomized to the control arm of the study
all receive usual professional development courses for
obesity management through Alberta Health Services
and the PCN, which includes didactic training on the
5As of Obesity Management tool kit. Control providers
will not take part in bi-weekly learning collaboratives,
will not be given circulated learning materials, and will
not receive added support from practice facilitators.
Provider-level study
To test the effect of the 5AsT intervention, we will con-
duct a pragmatic, mixed methods, allocation concealed,randomized, blinded (outcome, data analysts), clinical
trial. Figure 1 (upper) details the provider-level study.
Hypotheses
1. Implementation of the 5AsT in primary care practice
will increase the number of weight management visits
per FTE conducted by the PCN RN/NPs. The primary
outcome measure is the number of weight management
visits as a function of provider full time equivalent (FTE)
work (i.e., a half time nurse has an FTE of 0.5).
2. Implementation of the 5AsT in primary care practice
will result in sustained changes in medical practice as
evaluated by the RE-AIM framework [13,14].
Qualitative primary question
What contextual factors affect the number of weight
management visits conducted by the PCN practitioners?
Allocation concealment and randomization
Following ethical approval and study registration, the
eligible clinics (N = 24) were allocation concealed and
randomized in a 1:1 ratio using a computer generated
random sequence by a statistician external to the pro-
ject. Randomization was stratified for larger vs. smaller pa-
tient panel sizes. Three strata with eight practices were
created from the 24 eligible practice units. The first 8
units (Group 1) have panel size ≤2,754; Group 2 has clinic
panel size from 2,755 to 6,576, and Group 3 has clinic
panel size ≥6,577.
Outcome ascertainment, blinding and equal treatment
The primary outcome measure is the number of weight
management visits conducted by the RN/NP participants
in their individual practices. Their practice involves
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visits, diabetes care, and other chronic disease manage-
ment visits.
The primary outcome measure is a routine measure of
clinical activity collected on standardized forms within
the PCN at every clinical encounter; there is already an
audit and quality assurance process in place for this
measure. Due to the fact some provider participants
work part time, or fractional FTE (full-time equivalent),
this must be included in the primary outcome measure.
The provider subjects will be blinded to knowledge of
the primary outcome measure so as not to influence
their behavior in data collection. The research team will
not be involved with the collection of the primary out-
come measure. The investigators and health practi-
tioners will have no access to this data and will remain
blinded to the results until 12 months following imple-
mentation. Data analysts will remain blinded to the allo-
cation of intervention versus control.
Aside from the 5AsT intervention programming, there
is no difference in treatment between the intervention
and control practitioners. The RN/NPs’ clinical practices
are geographically dispersed and do not routinely interact.
Quantitative statistical analysis plan
The data will be stored in PCN clinical database and will
be extracted after the 12-month intervention and passive
period. We will assess the outcome at baseline, 3-month,
6-month, and 12-month time points. The data will be
analyzed for multiple time points to allow for a compari-
son between immediate and long-term provider impact
and to increase the reliability of observed trends. Follow-
ing the sustainability period of 12 to 24 months, the data
will be extracted again, and analyzed by blinded data
analysts.
Primary outcomes
Two stage summary statistics will be used for the ana-
lysis of the primary outcome; the number of weight
management visits/FTE for each practitioner will be de-
rived for each time point, and the average of the weight
management visits/FTE for the intervention and the
control group will be calculated. Weight management
visit/FTE trends at pre-intervention, baseline, 3, 6, 12
and 18 months post intervention will be plotted to com-
pare the two groups.
The intervention group and control group will be com-
pared using Wilcoxon-Mann–Whitney test. As genera-
lized estimating equation (GEE) can adjust for clustering
effect and does not require a normal distribution, we will
perform GEE models to compare the 5AsT intervention
group and the control group for our primary outcome at
3, 6, 12 and 18 months. Analysis will be by intention to
treat.Power considerations
Power calculations were performed using both simple
and cluster randomization where each clinic is consid-
ered as a cluster and RNs are clustered within units. The
intra class correlation was estimated to be 0.40. Power
calculations with the two approaches were very similar.
Given the large numbers of units with only one nurse,
we opted in favor of a simple randomization approach.
Briefly, this initial approach was as follows:
For simple randomization, a power of 77% was esti-
mated from N = 31 (total number of nurses in the study).
The power for a clustered randomized trial was esti-
mated for two scenarios: in 24 clinics with an average of
two nurses per clinic, this resulted in a power of 80%; in
24 clinics with an average of one nurse per clinic, it re-
sulted in a power of 65%. These two were presented be-
cause we have 31 nurses in total, with an average of 1.3
nurses per clinic, and the exact calculation is not avail-
able because an integer is required. However, from the
two scenarios, the exact power should be somewhere be-
tween 65% and 80%, which is similar to the resulting
power from a simple randomization (77%), thus explain-
ing our rationale of opting for a simple randomization.
Effect size was determined using the 22 units for which
complete baseline data was available. The mean number
of weight management visits/FTE was 69.2 with a stand-
ard deviation of 48.1. The study will have 80% power to
detect an effect size of 1.19 (absolute difference of
57-weight management visits/FTE between intervention
and control groups).Qualitative data collection
Qualitative data will include description of context, imple-
mentation process, and effect of the 5AsT intervention on
provider behaviour change. The approach is summarized
in Table 2. Primary data sources for the intervention in-
clude guided field notes taken during bi-weekly learning
collaborative sessions, and logs kept by the clinical cham-
pion and the practice facilitators. Data sources for pro-
vider impact include semi-structured interviews with key
informants, and focus groups. Potential participants will
include all providers and key PCN implementation
personnel involved in the 5As Team project.Qualitative data handling and analysis
Analysis of qualitative data will continue throughout the
project. Immediately following each observed interven-
tion session, observers will meet at the PCN and con-
struct a composite field note of the event directly into
one of the team computers. Field notes will be entered
into NVIVO 10 software (QSR International, Burlington,
Mass.) Interviews will be audio recorded, transcribed
verbatim, and entered into NVIVO.
Table 2 Qualitative data collection plan
Method Justification Timeframe
Intervention Phase
Session field notes Description: context, implementation process. 0-6 months
Semi-Structured Interviews All 5AsT randomized providers. Baseline data: intervention content and
process feedback-loop.
Initial 3 months
Personal views and practice, values fit, clinic climate.
Focus Groups Evaluation of tools developed during sessions. 6 months
Passive Phase
Log book Diary notes of passive observations on clinical impact. 0–12 months Clinical Champion
Sustainability Phase
Focus Groups Best practices and intervention impact during the passive phase. 12-24 months
Data Mixing
Semi-structured interviews with key providers. Follow-up of emergent questions. 14-16 months
Semi-Structured interviews with selected patients. Contextual factors that may have influenced patient behaviors. 18-24 months
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lysis approach for this project [15-18]. Thematic analysis
refers to the systematic search for and identification of
common themes that are present in data (transcripts
and field notes). The unit of analysis will be the health-
care practitioner. Inductive rather than predetermined
coding was chosen in order to allow themes to emerge
from the data itself and reflects an exploratory rather
than explanatory approach.
All interview transcripts will be coded and compared
by more than one individual to ensure reliability. A cod-
ing manual will clearly outline code definitions and use.
A clear record of how themes were generated from raw
data will be reviewed by all team members.
Qualitative and quantitative data mixing
Qualitative data analysis will be conducted on an ite-
rative base and informs the intervention. The quantita-
tive data for the primary outcome measure, number of
weight management visits/FTE, will be collected in a
blinded fashion for the first 12 months. At this point,
the primary outcome measure will be analyzed. The
study team will then be un-blinded and results will be
compared with those from the qualitative analysis. It is
expected that themes emerging from qualitative data will
be reflected in patterns of quantitative data. Any correl-
ation, or lack thereof, will be explored using key infor-
mant semi-structured interviews and focus groups. The
purpose of this parallel mixed methods design is four-
fold: first, to avoid bias during qualitative analysis; sec-
ond, to explain any variability of the primary outcome
measure; third, to record elements of RE-AIM not cap-
tured in the quantitative measures for the different pro-
viders in the intervention group; and fourth, to monitor
the impact of context, and implementation process inpart allowing for real-time feedback loops to maximize
effective implementation.
Patient-level study
The 5AsT patient portion of the study occurs concur-
rently with the provider study. Figure 1 (lower) details
the patient-level study.
Hypotheses
1. Implementation of the 5AsT in primary care, in
addition to PCN weight management programs, will
improve patient important outcomes: primary measures
(weight, body mass index [BMI], Short Form 12-item
Health Survey [SF-12]) and secondary measures (blood
pressure [BP], waist circumference [WC], EuroQol EQ-5D
[EQ-5DTM], modified Patient Assessment of Chronic
Illness Care [PACIC] [19-22] and completion of recom-
mended biomedical testing for those age > 40 or diabetic).
2. Activated patients, as defined as those who have
elected to participate in PCN programming for weight
management, will have improvement in patient-important
outcomes with PCN programming.
3. Patients who attend 5AsT intervention practices will
see improved sustained results greater than in those who
attend practices that have standard PCN programming
alone.
Qualitative primary question
What contextual factors affect patient perception of
in-clinic weight management efforts?
Subject recruitment
A key feature of pragmatic trials is that the participants
reflect the population for which the treatment is intended.
For the widest generalizability, it is therefore essential that
Table 3 Demographic characteristics and health variables
to be collected on patients
Age in years (mean ± SD) BMI (mean ±SD)
Gender (% female) Weight status (%):
Ethnic group: • Overweight:
Caucasian (%) • Obese:























PACIC score (mean ±SD)
Distance to practice (mean±SD) SF-12 (mean ±SD)
EQ5D (mean ±SD)
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will be all adult patients older than 18 years with a
BMI ≥25, enrolling in PCN programs for health, able
and willing to give written informed consent in English.
Children and pregnant women will be excluded. Since this
is a trial of the primary care management of obesity, pa-
tients whose obesity is co-managed by an obesity specialist
or tertiary care center will also be excluded (e.g., patients
referred for bariatric surgery), as well as patients who are
unable to participate in regular clinic visits or programs
due to geographic, social or physical reasons.
Power considerations
The sample size calculation for the patient cohort study
is powered based upon the SF-12 and the BMI. For SF-12,
a moderate effect size is 0.3, and for a 5% reduction in
BMI, a moderate effect size is 0.23 to 0.25. We will aim
for 80% power. We will gear our enrolment goal to antici-
pate a 30% lack of adherence to the complete measure-
ment protocol, ensuring that in this scenario the power
will remain reasonable at 70%.
Procedures: enrollment and data collection visits
Due to ethical and logistical considerations, we were not
permitted to randomize directly at the patient level.
Thus, we have randomized at the clinic level. We cannot
control how many patients enter the evaluation from
each clinic, but based on baseline practice size data, we
anticipate that there should be balanced representation
from 5AsT and control clinics.
Activated patients will be approached for recruitment
into the study. Signed informed consent will be obtained
at the PCN by trained staff. Patient visits will occur at
baseline, 3, 6, 12 and 18 months at the PCN. We will en-
deavour to have a minimum of 6 months of data on all
patients; thus recruitment must end in October 2015
to close the study by end of March 2016. Proposed base-
line characteristics of the patients will also be included
(Table 3).
Patient assessment includes: baseline demographics
and chronic disease presence (Table 3), measures of self-
reported quality of life (EQ5D, SF-12), for follow-up visits
a survey on weight management as a chronic disease
(modified PACIC, self-report of change behaviour, i.e.
gym participation, external weight loss programs, num-
ber of visits to a healthcare provider for weight manage-
ment), and measurement of resting heart rate, blood
pressure, and basic anthropometric measurements
(including height, weight, waist circumferences). We will
also monitor compliance with recommended laboratory
studies (HbA1c for those with diabetes q 6 months, and
for patients over 40 years, fasting cholesterol panel
and glucose). If patients are unable to participate in
the follow-up in person, a telephone option will beoffered. The in-person visit will take 30 minutes per
visit on up to five occasions.Quantitative data analysis: patient study
Demographic and health variables (Table 3) will be
compared using either t-test for continuous variables or
chi-square test for categorical variables. Main outcome
measures are SF-12 and change in weight and BMI.
Practice level clustering effects on the secondary out-
comes, multilevel models (random effects model) will be
considered. Adjustments will be made for individual level
characteristics, the random factor (intervention or control
practice), nurse and other practice level characteristics.
Changes at follow-up will be analyzed using multilevel
models with the baseline values as a covariate and to
handle missing data [23]. Data modeling is hypothesis-led
rather than data-driven, hence all analysis are predeter-
mined. STATA 12 (StataCorp, TX, USA) will be used
for statistical analyses.Selection of participants for qualitative patient sub-study
At 12 months, a sample of patients who agreed to be
contacted will be selected and consented for individual
semi-structured interviews. This will address patient-
specific experiences of PCN weight management efforts.
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range of individuals. We will use a pragmatic approach,
sampling until thematic saturation is reached. Selection
factors will include 5AsT versus control practice affili-
ation, weight loss success, comorbid medical conditions,
and PCN program attendance. Results of the quantita-
tive and qualitative data merge will determine the focus
and extent of patient interviews and sub-analyses.Qualitative data handling and analysis
Patient interviews will be handled and analyzed using
the same techniques and tools as the provider study. The
codebook created for the provider study will influence
transcript coding.Trial status
The 5AsT has been approved by the University of
Alberta ethics board and has been registered at Trials.gov
(NCT01967797). It is funded by an Alberta Innovates
Health Solutions grant.Discussion
The 5AsT trial is a theoretically informed, pragmatic
trial that uses a multi-level collaborative approach to aim
to sustainably change practitioner behaviors to improve
obesity management in primary care.
This project is grounded in established theoretical
frameworks for behavior change and complex innova-
tions and leverages bi-directional knowledge translation
between clinical and academic partners to comprehen-
sively evaluate the implementation of the 5AsT practice
change intervention.
Evaluation guided by the RE-AIM framework is par-
ticularly useful for determining programs that work in
real-world environments [13]. By widening the evalu-
ative focus beyond efficacy, the overall suitability and
investment-to-results assessment of the intervention can
be made.
As suggested in the conceptual framework of complex
innovation implementation Complex Innovations, pro-
cess is distinct from the evaluation of the 5AsT pro-
viders’ behaviour change [11]. We will use a rigorous
mixed-methods study design to distinguish issues with
implementation process from effectiveness of the in-
tervention. Maximal systemic impact of the research is
attained by implementing an integrated approach for
sustainability at the outset of the project [24]. Sustain-
ability will be achieved by leveraging existing clinical re-
sources and infrastructure. We will continue to monitor
the primary outcome measure for another year post the
intervention phase of the project.Main findings/messages
This research proposal uses a pragmatic design particu-
larly suited for evaluating the complex, real-world inter-
ventions typical of primary care settings [13]. Pragmatic
trials measure effectiveness (i.e., the degree of beneficial
effect in real clinical practice) and are conducted on par-
ticipants who represent the full spectrum of the popu-
lation to which the treatment might be applied. It is
important to extensively describe the context and popu-
lation in detail. In addition to the complexity of this re-
search setting, our target patient population (patients
who are overweight or obese) constitute one additional
level of complexity, given the large variability in the eti-
ology, comorbidity, and drivers of obesity as well as the
variable compliance, readiness to change, and treatment
preferences. Nevertheless, a key methodological issue in
pragmatic trials is finding the right balance between ex-
ternal and internal validity [25]. Provider behaviour is a
key feature in any primary care intervention. If providers
do not have the skills, beliefs and confidence to be able
to intervene effectively with patients, there will not be
an improvement in obesity management in primary care.
The 5AsT trial aims to understand what provider factors
are instrumental to increase the quality of obesity man-
agement in primary care.
Strengths
The strengths of this study are that it is a pragmatic
intervention conducted in a real-world setting of a large
and diverse Primary Care Network. The mixed methods
study design will provide contextual insights into the
intervention process and the outcomes. The bidirectional
nature of the design of the intervention will ensure rele-
vance to practitioners.
Limitations
The pragmatic nature of the study design limits the abil-
ity to restrict or steer patients’ access to programming
within the system, resulting in possible imbalance between
practice contributions to the patient cohort. Furthermore,
the dynamic and evolving clinical environment may result
in shifting context and priorities within the network over
time. Generalizability to other primary care networks and
practitioners may require further adaption and interven-
tion strategies tailored to those settings.
Summary
The 5AsT trial addresses a need for knowledge exchange
around obesity management in primary care in a prac-
tical and sustainable format geared towards real-life situa-
tions. The use of existing resources, collaborative design,
practice facilitation, and integrated feedback loops culti-
vate an applicable, repeatable and adaptable approach to
increasing the quality and quantity of primary care weight
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rich material to evaluate intervention effectiveness. A
comprehensive 5AsT intervention implementation plan
will address identified key barriers to obesity management
in primary care.
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